# BioNTechs Oncology Pivot Gets Real

- slug: biontechs-oncology-pivot-gets-real
- date: 2026-04-13
- category: Biotech & Life Sciences

A 49% response rate in recurrent endometrial cancer where chemo delivers 15% is the strongest evidence yet that BioNTechs post-pandemic oncology pivot is beginning to deliver.

---